Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Income from Continuing Operations: 2010-2012

Historic Income from Continuing Operations for Sonoma Pharmaceuticals (SNOA) over the last 3 years, with Dec 2012 value amounting to -$954,000.

  • Sonoma Pharmaceuticals' Income from Continuing Operations rose 63.49% to -$954,000 in Q4 2012 from the same period last year, while for Dec 2012 it was -$4.6 million, marking a year-over-year increase of 36.33%. This contributed to the annual value of -$7.4 million for FY2012, which is 6.50% up from last year.
  • As of Q4 2012, Sonoma Pharmaceuticals' Income from Continuing Operations stood at -$954,000, which was up 12.96% from -$1.1 million recorded in Q3 2012.
  • In the past 5 years, Sonoma Pharmaceuticals' Income from Continuing Operations registered a high of -$782,000 during Q2 2012, and its lowest value of -$2.6 million during Q4 2011.
  • Over the past 3 years, Sonoma Pharmaceuticals' median Income from Continuing Operations value was -$1.7 million (recorded in 2010), while the average stood at -$1.6 million.
  • Examining YoY changes over the last 5 years, Sonoma Pharmaceuticals' Income from Continuing Operations showed a top increase of 64.11% in 2012 and a maximum decrease of 27.59% in 2012.
  • Over the past 3 years, Sonoma Pharmaceuticals' Income from Continuing Operations (Quarterly) stood at -$2.2 million in 2010, then fell by 19.59% to -$2.6 million in 2011, then spiked by 63.49% to -$954,000 in 2012.
  • Its last three reported values are -$954,000 in Q4 2012, -$1.1 million for Q3 2012, and -$782,000 during Q2 2012.